Litcius/Paper detail

Pazopanib based oral metronomic therapy for platinum resistant/refractory epithelial ovarian cancer: A phase II, open label, randomized, controlled trial

Aparna Sharma, Mayank Singh, Ravi Chauhan, Prabhat Singh Malik, Sachin Khurana, Sandeep Mathur, Sunesh Kumar, Vishnubhatla Sreenivas, Lalit Kumar

2021Gynecologic Oncology22 citationsDOI

Topics & Concepts

PazopanibMedicineOncologyOpen labelRefractory (planetary science)Ovarian cancerInternal medicineRandomized controlled trialEpithelial ovarian cancerCancerSunitinibPhysicsAstrobiologyOvarian cancer diagnosis and treatmentPARP inhibition in cancer therapyAdvanced Breast Cancer Therapies
Pazopanib based oral metronomic therapy for platinum resistant/refractory epithelial ovarian cancer: A phase II, open label, randomized, controlled trial | Litcius